Condensed Consolidated Statements of Comprehensive Loss (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Income Statement [Abstract]
Revenue:	$ 0	$ 0	$ 0	$ 0
Total revenues	0	0	0	0
Operating expenses:
Research and development	456,280	462,517	771,592	1,018,699
General and administrative	771,533	654,523	1,367,253	1,353,532
Total operating expenses	1,227,813	1,117,040	2,138,845	2,372,231
Loss from operations	(1,227,813)	(1,117,040)	(2,138,845)	(2,372,231)
Interest (expense) income	(353,404)	0	(542,428)	3,926
Net loss	(1,581,217)	(1,117,040)	(2,681,273)	(2,368,305)
Other comprehensive loss:
Foreign currency translation adjustment	(19,333)	(7,401)	(14,510)	(23,152)
Comprehensive loss	$ (1,600,550)	$ (1,124,441)	$ (2,695,783)	$ (2,391,457)
Loss per share:
Basic and diluted	$ (0.07)	$ (0.05)	$ (0.12)	$ (0.11)
Weighted average number of shares outstanding	22,390,114	20,802,197	21,638,907	20,792,967